RecoverLINK Technology Pilot for HF Patients

Description

The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.

Study Start Date

February, 01 2016

Estimated Completion Date

June 2018

Interventions

  • Other: RecoverLINK technology

Study ID

RecoverLINK -- IF1793800

Status

Unknown

Trial ID

NCT02815085

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

63

Sponsor

RecoverLINK

Inclusion Criteria

  • Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic
  • English-speaking
  • With either access to (i) an iOS smart device or (ii) wifi at-home

Exclusion Criteria

    Patients meeting any of the following criteria:
  • A heart transplant
  • A mechanical circulatory support (MCS) device
  • An altered mental status
  • Serious co-morbidities (as identified by Mount Sinai team)
  • Cognitive impairments (as identified by Mount Sinai team)
  • Inability to use technology (as identified by Mount Sinai team)

Gender

All

Ages

N/A

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
The Mount Sinai Hospital - New York, New York 46.8 miles ADV HF Clinic 212-241-1000 None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.